Li Yuhang, Song Yinghui, Zhang Yujing, Liu Sulai
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Central Laboratory of Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Front Oncol. 2022 Aug 22;12:966835. doi: 10.3389/fonc.2022.966835. eCollection 2022.
Gallbladder cancer (GBC) is a malignant tumor that originates from the mucosal lining of the gallbladder. It is distinctly regional and is common in certain geographic regions of developing countries. GBC has a high degree of insidiousness as well as a high propensity for metastatic spread, resulting in the majority of patients being diagnosed at an advanced stage. Lymph node metastasis (LNM) is fairly common in GBC patients and is an independent risk factor for a poor prognosis. This article is focused on the lymph node pathways and metastatic directions of GBC. Furthermore, it summarizes the different lymph node groupings, disease stages and treatments. In the future, it is of great significance to develop individualized treatment and predict the outcomes of GBC patients with different lymph node conditions.
胆囊癌(GBC)是一种起源于胆囊黏膜内衬的恶性肿瘤。它具有明显的区域性,在发展中国家的某些地理区域较为常见。胆囊癌具有高度隐匿性以及高转移扩散倾向,导致大多数患者在晚期才被诊断出来。淋巴结转移(LNM)在胆囊癌患者中相当常见,并且是预后不良的独立危险因素。本文重点关注胆囊癌的淋巴结途径和转移方向。此外,它总结了不同的淋巴结分组、疾病阶段和治疗方法。未来,制定个体化治疗方案并预测不同淋巴结状况的胆囊癌患者的预后具有重要意义。